Showing results (1211-1220 of 1,555) with videos related to

Sort By:
Pageof 156
Contemporary Clinical Trials Communications|April 8, 2020
Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approachSarah H Snider, Patrick A Flume, Stephanie L Gentilin, et al.
Contemporary Clinical Trials Communications|April 8, 2020
Covariate-constrained randomization for cluster randomized trials in the long-term care setting: Application to the TRAIN-AD trialMichele L Shaffer, Erika M C D'Agata, Daniel Habtemariam, et al.
Contemporary Clinical Trials Communications|October 26, 2019
Qualitative analysis of COACH: A community-based behavioral intervention to reduce obesity health disparities within a marginalized communityWilliam J Heerman, Jesse Cole, Leah Teeters, et al.
Contemporary Clinical Trials Communications|October 26, 2019
mHealth nutrition and lifestyle intervention (mHENAL) to reduce cardiovascular disease risk in a middle-aged, overweight and obese population in Sri Lanka: Study protocol for a randomized controlled trialUpul Senarath, Prasad Katulanda, Dulitha N Fernando, et al.
Contemporary Clinical Trials Communications|October 26, 2019
Design and outcome measures for the AB InBev Global Smart Drinking Goals evaluationTed R Miller, Christopher L Ringwalt, Joel W Grube, et al.
Contemporary Clinical Trials Communications|May 19, 2021
Written exposure therapy and app-delivered mindfulness-based meditation for PTSD and subthreshold PTSD in China: Design of a randomized controlled trialMuyang Li, Bingsu Wang, Qiang Chen, et al.
Contemporary Clinical Trials Communications|May 20, 2021
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial designRobert M Haws, Gregory Gordon, Joan C Han, et al.
Contemporary Clinical Trials Communications|August 17, 2021
BaSAlt - A mixed-methods study protocol on setting-based physical activity promotion and counseling in nursing homesA Thiel, G Sudeck, A Niess, et al.
Contemporary Clinical Trials Communications|August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patientsMiko Yamada, Dennis M Miller, Melinda Lowe, et al.
Contemporary Clinical Trials Communications|May 24, 2021
The importance of loss functions: A note on the evolution of the Toxicity Probability Interval designJonathan Siegel
Pageof 156